Where do Bicara Therapeutics's ratios come from?

Every ratio is computed from Bicara Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Liquidity
Current ratio	13.9×-0.7×	14.6×+0.4×	14.1×-11.7×	25.8×—	——
Quick ratio	13.9×-0.7×	14.6×+0.4×	14.1×-11.7×	25.8×—	——
Cash ratio	8.2×+4.9×	3.3×-4.8×	8.2×-17.2×	25.3×—	——
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×—	——
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×—	——
Per Share
Book value per share	$8.46+15.3%	$7.34-0.5%	$7.38-7.5%	$7.98-5.3%	$8.43-71.2%
Valuation
Market capitalization	$1.29B+39.8%	$921.98M+7.0%	$861.55M—	——	——
Enterprise value	$966.81M+16.9%	$827.01M+19.5%	$691.85M—	——	——
Price / book	2.5×+0.2×	2.3×+0.2×	2.1×—	——	——
Free cash flow yield	-9%+2.6pp	-11.6%+1.5pp	-13.1%—	——	——
Earnings yield	-12.2%+2.8pp	-15%-0.9pp	-14.1%—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Bicara Therapeutics's ratios come from?: Every ratio is computed from Bicara Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.